IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Immatics N.V.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026
$7.05+0.32 (+4.75%)
Close on Oct 19, 2026
Fundamental chart
Pick a measure to chart its full history
-€182.02MFY2025